Safety of axicabtagene ciloleucel for the treatment of relapsed or refractory large B-cell lymphoma

Publication date: Available online 8 October 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Allison Grana, Natalia Gut, Kiersten Williams, Joseph Maakaron, Kyle Porter, Basem M. William, Sumithira Vasu, Sam Penza, Jonathan E. Brammer, Ayman Saad, Marcin Puto, Samantha M. Jaglowski, Julianna Roddy
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research